North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative.

导出原文传递

翻译打印收藏纠错

第一作者： Jai N,Patel

第一单位： Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA.

作者： Jai N,Patel ^[1] ; Deepak,Voora ^[2] ; Gillian,Bell ^[3] ; Jill,Bates ^[4] ; Amber,Cipriani ^[5] ; Lisa,Bendz ^[6] ; Amber,Frick ^[2] ; Issam,Hamadeh ^[6] ; Ann S,McGee ^[1] ; Nury,Steuerwald ^[2] ; Sara,Imhof ^[1] ; Tim,Wiltshire ^[7]

作者单位： Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA. ^[1] Center for Applied Genomics & Precision Medicine, Duke University & Duke Health System, Durham, NC 27710, USA. ^[2] Department of Genetics & Personalized Medicine, Mission Health, Asheville, NC, 28801, USA. ^[3] Genome Medical, Inc., South San Francisco, CA 94080, USA. ^[4] Department of Pharmacy, Durham VA Healthcare System, Durham, NC 27705, USA. ^[5] Division of Pharmacotherapy & Experimental Therapeutics, The University of North Carolina Chapel Hill Eshelman School of Pharmacy & UNC Health, Chapel Hill, NC 27514, USA. ^[6] North Carolina Biotechnology Center, Durham, NC 27709, USA. ^[7]

关键词 North Carolina genomics pharmacogenomics precision health

主题词抗体多样性(Antibody Diversity);医院, 大学(Hospitals, University);人类(Humans);北卡罗来纳(North Carolina);遗传药理学(Pharmacogenetics);公营-私营部门合作(Public-Private Sector Partnerships);研究(Research)

DOI 10.2217/pgs-2020-0156

PMID 33448876

发布时间 2021-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交